SCHEMBL17894697

SCHEMBL17894697

CC(F)(F)c1ccc(C(O)C(=O)c2ccccc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CES2 O00748 5/20 0.63
CES1 P23141 5/20 0.63
LMNA P02545 3/20 0.62
ALDH1A1 P00352 3/20 0.52
TSHR P16473 1/20 0.52
HSD17B10 Q99714 1/20 0.52
KDM4E B2RXH2 1/20 0.50
PTPN1 P18031 2/20 0.49
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MAPK1 P28482 1/20 0.40
CYP3A4 P08684 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17894698 0.94 CES2 (0.63) CES2CES1LMNAALDH1A1TSHR
SCHEMBL6758776 0.87 ALDH1A1 (0.68) CES2CES1LMNAALDH1A1TSHR
SCHEMBL5445265 0.87 CES2 (0.83) CES2CES1LMNAALDH1A1TSHR
SCHEMBL4331474 0.80 ALDH1A1 (0.68) CES2CES1LMNAALDH1A1TSHR
Benzoin SCHEMBL2961461 0.79 CES2 (0.70) CES2CES1LMNAALDH1A1KDM4E
Benzoin SCHEMBL4557692 0.79 LMNA (0.91) CES2CES1LMNAALDH1A1HSD17B10
Benzoin SCHEMBL145 0.78 CES2 (1.00) CES2CES1LMNAALDH1A1TSHR
Benzoin SCHEMBL901258 0.78 CES2 (1.00) CES2CES1LMNAALDH1A1TSHR
Benzoin SCHEMBL2025536 0.78 CES2 (1.00) CES2CES1LMNAALDH1A1TSHR
Benzoin SCHEMBL10665271 0.78 CES2 (1.00) CES2CES1LMNAALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3240791-A1 PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS Forma Therapeutics, Inc. (US) 2017-11-08 EP disclosed
WO-2016109515-A1 PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS FORMA THERAPEUTICS, INC. (US) 2016-07-07 WO disclosed